Altor BioScience's Series C Round

Altor BioScience raised a round of funding on April 09, 2007. Investors include TVM Capital.

Altor BioScience is a biopharmaceutical company engaged in the discovery, development and commercialization of high-value, targeted immunotherapeutic agents for the treatment of cancer, viral infectio…

Articles about Altor BioScience's Series C Round: